GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CellSeed 7776.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

165

+3.13%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥83.7m

FY2016FY2025

Net income

−¥1.10bn

FY2016FY2025

Free cash flow

−¥1.02bn

FY2016FY2025

Shareholders' equity

¥1.27bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue¥83.7m¥193.3m¥190.1m¥126.4m¥161.7m¥199.5m¥275.8m¥1.03bn¥85.1m¥100.7m
Gross profit¥42.7m¥110.1m¥107.2m¥61.0m¥84.0m¥138.2m¥216.6m¥994.5m¥51.0m¥80.8m
Research and development¥720.1m¥573.3m¥456.4m¥444.8m¥541.2m¥438.8m¥591.4m¥432.6m¥632.3m¥1.07bn
Operating income−¥1.05bn−¥846.4m−¥697.8m−¥745.9m−¥906.1m−¥769.5m−¥826.0m¥140.1m−¥959.5m−¥984.5m
Net income−¥1.10bn−¥859.8m−¥846.5m−¥759.7m−¥912.9m−¥783.9m−¥782.4m¥129.7m−¥966.5m−¥1.41bn
Diluted earnings per share-31.74-24.80-27.04-33.08-51.40-48.97-60.2711.36-84.57-36.29

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets¥1.66bn¥2.43bn¥2.47bn¥1.54bn¥1.41bn¥1.81bn¥1.46bn¥1.59bn¥1.56bn¥1.34bn
Cash and short-term investments¥1.32bn¥2.13bn¥2.16bn¥1.07bn¥846.7m¥1.46bn¥1.07bn¥1.06bn¥1.35bn¥1.06bn
Total liabilities¥387.5m¥269.9m¥301.0m¥365.6m¥363.6m¥280.1m¥110.4m¥174.7m¥303.1m¥179.1m
Debt¥132.9m¥143.8m¥151.3m¥158.8m¥160.0m¥160.0m————
Shareholders' equity¥1.27bn¥2.16bn¥2.16bn¥1.18bn¥1.04bn¥1.53bn¥1.35bn¥1.41bn¥1.26bn¥1.16bn
Shares outstanding35m35m31m23m18m16m13m11m11m39m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−¥989.0m−¥866.1m−¥779.4m−¥718.0m−¥817.2m−¥700.7m−¥577,000−¥306.0m−¥747.0m−¥852.0m
Capital spending−¥26.2m−¥18.4m−¥21.6m−¥15.6m−¥91.0m−¥10.3m−¥13,000−¥1.0m−¥5.0m−¥343.6m
Free cash flow−¥1.02bn−¥884.5m−¥801.1m−¥733.6m−¥908.2m−¥711.0m−¥590,000−¥307.0m−¥752.0m−¥1.20bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥7.2m¥13.7m¥18.4m¥28.3m¥10.2m¥26.8m¥55.0m¥61.9m
Gross profit¥3.9m¥7.6m¥10.5m¥17.9m¥5.2m¥9.1m¥31.2m¥37.2m
Operating income−¥320.6m−¥250.3m−¥221.5m−¥201.3m−¥230.7m−¥392.6m−¥181.9m−¥200.3m
Net income−¥338.4m−¥272.2m−¥254.6m−¥198.3m−¥257.4m−¥393.7m−¥180.4m−¥205.0m
Diluted earnings per share-8.68-6.99-7.32-5.70-7.40-11.32-5.20-5.91
Total assets¥2.08bn¥2.37bn¥1.66bn¥1.67bn¥1.91bn¥2.23bn¥2.43bn¥2.62bn
Cash and short-term investments¥1.79bn¥2.01bn¥1.32bn¥1.37bn¥1.66bn¥1.92bn¥2.13bn¥2.34bn
Debt¥116.9m¥27.5m¥132.9m¥27.5m¥139.4m¥17.5m¥10.8m¥7.5m
Shareholders' equity¥1.77bn¥2.00bn¥1.27bn¥1.31bn¥1.51bn¥1.77bn¥2.16bn¥2.34bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-12.9%-15.9%-8.0%
Operating income11.9%6.3%6.3%
Net income13.3%7.1%7.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.2%54.1%56.9%75.3%
Operating margin-683.3%-562.1%-525.0%-311.5%
Net margin-709.1%-601.5%-551.7%-335.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-8.2-16.1-10.0-5.1-3.6-5.0-8.658.8-5.5-14.8
Price to sales107.771.644.630.520.219.824.27.462.1207.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.